ACAD
37.22
-0.95
-2.49%
AEMD
7.594
+0.544
+7.716%
APRI
1.67
+0.32
+23.70%
ARNA
2.685
-0.025
-0.923%
ATEC
0.578
+0.038
+7.037%
CNAT
4.02
-0.03
-0.74%
CRXM
0.33
-0.04
-10.80%
CYTX
0.361
+0.046
+14.6667%
DXCM
93.88
-0.31
-0.33%
GNMK
10.19
+0.17
+1.6956%
HALO
17.61
-0.8
-4.35%
ILMN
197.74
-3.96
-1.96%
INNV
0.148
0.00
0.00%
INO
7.551
-0.179
-2.316%
ISCO
3.9
-0.08
-2.01%
ISIS
49.89
-1.65
-3.20%
LGND
93.47
-1.57
-1.65%
LPTN
0.228
+0.003
+1.333%
MBVX
1.76
+0.08
+4.45%
MEIP
1.81
+0.08
+4.6185%
MNOV
2.97
+0.03
+1.02%
MRTX
25.97
-0.69
-2.59%
MSTX
0.482
+0.012
+2.6383%
NBIX
46.62
-0.05
-0.11%
NUVA
52.74
-1.01
-1.88%
ONCS
5.2
0.00
0.00%
ONVO
2.754
+0.214
+8.4094%
OREX
2.785
-0.105
-3.633%
OTIC
23.709
+0.209
+0.889%
QDEL
20.47
+0.02
+0.10%
RCPT
231.96
0.00
0.00%
RGLS
8.38
+0.11
+1.33%
RMD
51.92
-0.55
-1.05%
SCIE
0.014
0.00
-2.7586%
SPHS
0.885
-0.005
-0.562%
SRNE
12.87
-0.78
-5.71%
TROV
6.012
-0.318
-5.0174%
VICL
0.6
+0.01
+1.6610%
VOLC
18
0.00
0.00%
ZGNX
19.13
+0.72
+3.91%
ACAD
37.22
-0.95
-2.49%
AEMD
7.594
+0.544
+7.716%
APRI
1.67
+0.32
+23.70%
ARNA
2.685
-0.025
-0.923%
ATEC
0.578
+0.038
+7.037%
CNAT
4.02
-0.03
-0.74%
CRXM
0.33
-0.04
-10.80%
CYTX
0.361
+0.046
+14.6667%
DXCM
93.88
-0.31
-0.33%
GNMK
10.19
+0.17
+1.6956%
HALO
17.61
-0.8
-4.35%
ILMN
197.74
-3.96
-1.96%
INNV
0.148
0.00
0.00%
INO
7.551
-0.179
-2.316%
ISCO
3.9
-0.08
-2.01%
ISIS
49.89
-1.65
-3.20%
LGND
93.47
-1.57
-1.65%
LPTN
0.228
+0.003
+1.333%
MBVX
1.76
+0.08
+4.45%
MEIP
1.81
+0.08
+4.6185%
MNOV
2.97
+0.03
+1.02%
MRTX
25.97
-0.69
-2.59%
MSTX
0.482
+0.012
+2.6383%
NBIX
46.62
-0.05
-0.11%
NUVA
52.74
-1.01
-1.88%
ONCS
5.2
0.00
0.00%
ONVO
2.754
+0.214
+8.4094%
OREX
2.785
-0.105
-3.633%
OTIC
23.709
+0.209
+0.889%
QDEL
20.47
+0.02
+0.10%
RCPT
231.96
0.00
0.00%
RGLS
8.38
+0.11
+1.33%
RMD
51.92
-0.55
-1.05%
SCIE
0.014
0.00
-2.7586%
SPHS
0.885
-0.005
-0.562%
SRNE
12.87
-0.78
-5.71%
TROV
6.012
-0.318
-5.0174%
VICL
0.6
+0.01
+1.6610%
VOLC
18
0.00
0.00%
ZGNX
19.13
+0.72
+3.91%
Home » Archive by Category

Xconomy

Tax Time Alert: Key Things to Know About Founders Preferred Stock

April 10, 2015 – 6:11 am

As you gather and review tax papers for your return, be sure to inform your accountant if you hold founders’ preferred stock, or if you sold a block of it in 2014. Your CPA might not think to ask you…

[[Click headline to continue reading.]]

After raising $76M in Series E Round, aTyr Pharma Files for IPO

April 7, 2015 – 7:33 am

San Diego’s aTyr Pharma, which raised $76 million last week from a group of venture and institutional crossover investors, intends to raise an additional $86.2 million through an IPO, according to a…

[[Click headline to continue reading.]]

After raising $76M in Series E Round, aTyr Pharma Files for IPO

April 7, 2015 – 7:33 am

San Diego’s aTyr Pharma, which raised $76 million last week from a group of venture and institutional crossover investors, intends to raise an additional $86.2 million through an IPO, according to a…

[[Click headline to continue reading.]]

After raising $76M in Series E Round, aTyr Pharma Files for IPO

April 7, 2015 – 7:33 am

San Diego’s aTyr Pharma, which raised $76 million last week from a group of venture and institutional crossover investors, intends to raise an additional $86.2 million through an IPO, according to a…

[[Click headline to continue reading.]]

Prenatal Screener Natera Grabs $55M, Considers Cancer Test

April 6, 2015 – 12:47 pm

[Updated 4/7/15, 5:13 pm. See below.] In the increasingly active genetic testing space, Natera is trying to lead the pack by harnessing its testing capabilities. And it has plenty of money to do so,…

[[Click headline to continue reading.]]

Prenatal Screener Natera Grabs $55M, Considers Cancer Test

April 6, 2015 – 12:47 pm

[Updated 4/7/15, 5:13 pm. See below.] In the increasingly active genetic testing space, Natera is trying to lead the pack by harnessing its testing capabilities. And it has plenty of money to do so,…

[[Click headline to continue reading.]]

Prenatal Screener Natera Grabs $55M, Considers Cancer Test

April 6, 2015 – 12:47 pm

[Updated 4/7/15, 5:13 pm. See below.] In the increasingly active genetic testing space, Natera is trying to lead the pack by harnessing its testing capabilities. And it has plenty of money to do so,…

[[Click headline to continue reading.]]

Gene Therapy’s Rebirth Continues With Bristol, UniQure Cardio Deal

April 6, 2015 – 6:19 am

There’s no doubt at this point that gene therapy research, after a decade proceeding in relative obscurity, is back. A host of companies are racing to find the best way to harness the science to…

[[Click headline to continue reading.]]

Gene Therapy’s Rebirth Continues With Bristol, UniQure Cardio Deal

April 6, 2015 – 6:19 am

There’s no doubt at this point that gene therapy research, after a decade proceeding in relative obscurity, is back. A host of companies are racing to find the best way to harness the science to…

[[Click headline to continue reading.]]

Gene Therapy’s Rebirth Continues With Bristol, UniQure Cardio Deal

April 6, 2015 – 6:19 am

There’s no doubt at this point that gene therapy research, after a decade proceeding in relative obscurity, is back. A host of companies are racing to find the best way to harness the science to…

[[Click headline to continue reading.]]